SynapDx has appointed Kevin Hrusovsky to the firm's board of directors. He most recently served as president of life sciences and technology at PerkinElmer. Hrusovsky had been CEO of Caliper Life Sciences from 2003 to 2011, when the firm was purchased by PerkinElmer for more than $600 million. He left PerkinElmer earlier this year but agreed to serve as a consultant for up to one year. He also serves on the board of directors of 908 Devices.
Paired Ends: Kevin Hrusovsky
Oct 15, 2013